Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03461120 · ClinicalTrials.gov registry record · Phase 4

Improving Postamputation Functioning by Decreasing Phantom Pain With Perioperative Continuous Peripheral Nerve Blocks: A Department of Defense Funded Multicenter Study

A Phase 4 study of Post-amputation Phantom Limb Pain and Lower Extremity Surgical Amputation, sponsored by University of California, San Diego.

Active
Registry status
Phase 4
Development phase
203
Enrollment target
8
Study locations

NCT03461120 is a Phase 4 study of Post-amputation Phantom Limb Pain and Lower Extremity Surgical Amputation that is active but no longer recruiting, run by University of California, San Diego. The registered enrollment target is 203 participants. The trial reports 8 study locations across 4 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03461120, a Phase 4 study of Post-amputation Phantom Limb Pain and Lower Extremity Surgical Amputation, is active but no longer recruiting, sponsored by University of California, San Diego.

ACTIVE NOT RECRUITING
Registry status
Phase 4
Development phase
203 participants
Enrollment target
8
Study locations

Study Summary

When a limb is amputated, pain perceived in the part of the body that no longer exists often develops, called "phantom limb" pain. The exact reason that phantom limb pain occurs is unclear, but when a nerve is cut-as happens with an amputation-changes occur in the brain and spinal cord that are associated with persistent pain. The negative feedback-loop between the injured limb and the brain can be stopped by putting local anesthetic-called a "nerve block"-on the injured nerve, effectively keeping any "bad signals" from reaching the brain. A "continuous peripheral nerve block" (CPNB) is a technique providing pain relief that involves inserting a tiny tube-smaller than a piece of spaghetti-through the skin and next to the target nerve. Local anesthetic is then introduced through the tiny tube, which bathes the nerve in the numbing medicine. This provides a multiple-day block that provides opioid-free pain control with no systemic side effects, and may prevent the destructive feedback loop that results in phantom limb pain following an amputation. We propose a multicenter, randomized, triple-masked (investigators, subjects, statisticians), placebo-controlled, parallel arm, human-subjects clinical trial to determine if a prolonged, high-concentration (dense), perioperative CPNB improves post-amputation physical and emotional functioning while decreasing opioid consumption, primarily by preventing chronic phantom limb pain.

Interventions

  • DRUG Experimental continuous peripheral nerve blocks
  • DRUG Control continuous peripheral nerve blocks

Study Locations (8)

Massachusetts

  • Mass. General Hospital - Boston
  • Brigham and Women's Hospital - Boston
  • Boston VA - Boston

California

  • University California San Diego - San Diego
  • Naval Medical Center San Diego - San Diego

Ohio

  • Fairview Hospital - Cleveland
  • Cleveland Clinic - Cleveland

Texas

  • University of Texas MD Anderson Cancer Center - Houston

Trial Details

FieldValue
Enrollment Target 203 participants
Start Date 2018-03-23
Est. Completion 2026-11-18
Phase Phase 4

Sponsor

University of California, San Diego

775 total trials

What the Registry Record Tells You About NCT03461120

The ClinicalTrials.gov registry entry for NCT03461120 describes a study currently listed as active not recruiting, categorized as Phase 4. The registered enrollment target is 203 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Post-amputation Phantom Limb Pain appearing as the primary indexed condition, and to 2 interventions - of which Experimental continuous peripheral nerve blocks is the first listed.

NCT03461120 reports 8 study locations spanning 4 distinct geographic areas - top geographies include Massachusetts, California, Ohio.

Frequently Asked Questions

What is clinical trial NCT03461120 about?

NCT03461120 is a clinical study titled "Improving Postamputation Functioning by Decreasing Phantom Pain With Perioperative Continuous Peripheral Nerve Blocks: A Department of Defense Funded Multicenter Study". When a limb is amputated, pain perceived in the part of the body that no longer exists often develops, called "phantom limb" pain. The exact reason that phantom limb pain occurs is unclear, but when a nerve is cut-as happens with an amputation-changes occur in the brain and spinal cord that are asso...

What is the current status of trial NCT03461120?

This trial is currently active not recruiting. It is a Phase 4 study. The enrollment target is 203 participants. The study started on 2018-03-23. Estimated completion is 2026-11-18.

What conditions does trial NCT03461120 study?

This clinical trial studies the following conditions: Post-amputation Phantom Limb Pain, Lower Extremity Surgical Amputation.

What interventions are being tested in trial NCT03461120?

The interventions under investigation include: Experimental continuous peripheral nerve blocks (DRUG), Control continuous peripheral nerve blocks (DRUG).

Who is sponsoring clinical trial NCT03461120?

This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03461120 being conducted?

This trial has 8 study locations across California, Massachusetts, Ohio, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Post-amputation Phantom Limb Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.